ES2090255T3 - Procedimiento para producir preparaciones de inmunoglobulina a secretora. - Google Patents

Procedimiento para producir preparaciones de inmunoglobulina a secretora.

Info

Publication number
ES2090255T3
ES2090255T3 ES91309096T ES91309096T ES2090255T3 ES 2090255 T3 ES2090255 T3 ES 2090255T3 ES 91309096 T ES91309096 T ES 91309096T ES 91309096 T ES91309096 T ES 91309096T ES 2090255 T3 ES2090255 T3 ES 2090255T3
Authority
ES
Spain
Prior art keywords
secretary
procedure
immunoglobulin preparations
producing immunoglobulin
immunoglobulin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91309096T
Other languages
English (en)
Inventor
Yoshikazu Yuki
Motoko Baba
Mitsuo Shimizu
Kazuo Kato
Hajime Hiratani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
JCR Pharmaceuticals Co Ltd
Original Assignee
JCR Pharmaceuticals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by JCR Pharmaceuticals Co Ltd filed Critical JCR Pharmaceuticals Co Ltd
Application granted granted Critical
Publication of ES2090255T3 publication Critical patent/ES2090255T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/04—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A61L2/04—Heat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00—Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05—Living organisms or biological materials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/861—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving IgG3, IgG4, IgA, or IgY

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

PREPARACIONES DE INMUNOGLOBULINA A SECRETORA QUE NO CONTENGAN VIRUS SE PRODUCEN MEDIANTE UN PROCESO EN EL CUAL LA INMUNOGLOBULINA A SECRETORA QUE PUEDE ESTAR CONTAMINADA CON VIRUS SE CALIENTA (1) HASTA ALREDEDOR DE 40 C DURANTE ALREDEDOR DE 10 HORAS, O SE EXPONE (2) A LA REACCION CON FOSFATO DE TRI-N-BUTIL Y UN SURFACTANTE Y AL CALENTAMIENTO SEGUN SE MENCIONO ANTERIORMENTE, COMO FORMA LICUIFICADA EN UN MEDIO ACUOSO Y POSTERIORMENTE LOS MATERIALES POLIMERIZADOS SE PRECIPITAN DE LA SOLUCION RESULTANTE MEDIANTE LA ADICCION DE POLIETILENOGLICOL A LA MISMA.
ES91309096T 1990-10-05 1991-10-03 Procedimiento para producir preparaciones de inmunoglobulina a secretora. Expired - Lifetime ES2090255T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP26920090A JP3145696B2 (ja) 1990-10-05 1990-10-05 分泌型免疫グロブリンａ製剤の製造法

Publications (1)

Publication Number Publication Date
ES2090255T3 true ES2090255T3 (es) 1996-10-16

Family

ID=17469069

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91309096T Expired - Lifetime ES2090255T3 (es) 1990-10-05 1991-10-03 Procedimiento para producir preparaciones de inmunoglobulina a secretora.

Country Status (6)

Country Link
US (1) US5371196A (es)
EP (1) EP0479597B1 (es)
JP (1) JP3145696B2 (es)
CA (1) CA2052809A1 (es)
DE (1) DE69120192T2 (es)
ES (1) ES2090255T3 (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3220539B2 (ja) * 1992-12-25 2001-10-22 日本ケミカルリサーチ株式会社 活性乳蛋白成分含有製品およびその製造法
CN1064552C (zh) * 1993-02-09 2001-04-18 奥克塔法马有限公司 失活无脂质被膜病毒的方法
DE4434538C2 (de) * 1993-10-06 2000-08-10 Immuno Ag Verfahren zur Virusinaktivierung in Gegenwart eines Polyethers und eines chaotropen Agens
HRP940645A2 (en) * 1993-10-06 1996-12-31 Immuno Ag Process for virus deactivation in the presence of polyalkylene glycol and the pharmaceutical preparation thus obtained
FI94993C (fi) * 1993-11-30 1995-11-27 Nokia Telecommunciations Oy Menetelmä radioyksikön ohjaamiseksi
DE19505287A1 (de) * 1994-02-18 1995-08-24 Immuno Ag Zusammensetzung und Verfahren zur Prävention und Behandlung von Entzündungen mit Immunglobulin A
DE4424935C1 (de) * 1994-07-14 1996-03-21 Immuno Ag Humanes virussicheres monomeres Immunglobulin A und Verfahren zu seiner Herstellung
US6034073A (en) * 1995-04-24 2000-03-07 Novavax, Inc. Solvent detergent emulsions having antiviral activity
FI955389A0 (fi) * 1995-11-09 1995-11-09 Antti Sakari Aaltonen Tandskyddande profylaktisk preparat och administreringsmedlen emot mellanoerpatogener
AU5082698A (en) * 1996-10-23 1998-05-15 Oravax, Inc Heat inactivation of viruses in antibody preparations
TW541179B (en) * 1997-03-19 2003-07-11 Green Cross Corp Process for preparing immunoglobulin preparation
DE59800935D1 (en) 1997-04-08 2001-08-02 Baxter Ag Immuntolerante prothrombinkomplex-präparation
AT405608B (de) * 1997-04-08 1999-10-25 Immuno Ag Verfahren zur inaktivierung von pathogenen, insbesondere von viren, in einem biologischen material
UA64742C2 (uk) * 1997-12-24 2004-03-15 Альфа Терапевтик Корпорейшн СПОСІБ ОДЕРЖАННЯ РОЗЧИНУ <font face="Symbol">g</font>-ГЛОБУЛІНУ, ПРИЗНАЧЕНОГО ДЛЯ ВНУТРІШНЬОВЕННОГО ВВЕДЕННЯ, І ПРОДУКТ, ЩО ОДЕРЖУЄТЬСЯ У ЦЕЙ СПОСІБ (ВАРІАНТИ)
US6162904A (en) * 1997-12-24 2000-12-19 Alpha Therapeutic Corporation Manufacturing method for intraveneously administrable immune globulin and resultant product
US6441144B1 (en) * 1999-05-20 2002-08-27 Alpha Therapeutic Corporation Method for repairing dual virally inactivated immune globulin for intravenous administration
CA2375560A1 (en) * 1999-06-15 2000-12-21 Alpha Therapeutic Corporation Manufacturing method for intravenous immune globulin and resultant product
CN101721362B (zh) 2002-02-14 2018-07-03 中外制药株式会社 包含抗体的溶液制剂
RU2296335C2 (ru) * 2004-06-09 2007-03-27 Галина Васильевна Виха Набор реагентов для количественного определения секреторного иммуноглобулина a в сыворотке и секретах организма человека методом одностадийного твердофазного иммуноферментного анализа
RU2277421C1 (ru) * 2005-04-05 2006-06-10 Государственное научное учреждение Всероссийский научно-исследовательский институт экспериментальной ветеринарии им. Я.Р. Коваленко Способ получения секреторного иммуноглобулина a из молозива рогатого скота
CN102124027B (zh) * 2008-05-15 2015-01-21 温氏健康有限公司 产生富含分泌型免疫球蛋白的乳组分的方法
EP2854848B1 (en) 2012-05-25 2016-10-26 Gottfried Himmler Secretory immunoglobulin deficiency treatment and prophylaxis
US9458230B2 (en) 2013-01-04 2016-10-04 Wisconsin Alumni Research Foundation Secretory IGA compositions, methods of making and methods of use thereof
US9468674B2 (en) 2013-09-24 2016-10-18 Wisconsin Alumni Research Foundation Methods of use of secretory IgA
ES2940650T3 (es) 2017-09-12 2023-05-10 Wisconsin Alumni Res Found Péptidos del receptor 2 de interleucina-10, anticuerpos, composiciones y métodos de uso de los mismos

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL286954A (es) * 1962-01-03
US3763135A (en) * 1971-11-08 1973-10-02 Baxter Laboratories Inc Gamma globulin production from cohn fraction iii using polyethylene glycol
US4124576A (en) * 1976-12-03 1978-11-07 Coval M L Method of producing intravenously injectable gamma globulin
US4439421A (en) * 1982-08-30 1984-03-27 Baxter Travenol Laboratories, Inc. Stabilized gamma globulin concentrate
US4540573A (en) * 1983-07-14 1985-09-10 New York Blood Center, Inc. Undenatured virus-free biologically active protein derivatives
JPH0669961B2 (ja) * 1984-09-25 1994-09-07 株式会社ミドリ十字 免疫グロブリンの加熱処理方法
JPH0825902B2 (ja) * 1985-02-21 1996-03-13 株式会社ミドリ十字 γ−グロブリンの加熱処理方法
EP0225581A3 (en) * 1985-11-30 1989-05-24 Green Cross Corporation Method for the heat-treatment of immunoglobulins and immunoglobulin product
ES2057191T5 (es) * 1989-01-13 2003-05-01 Mitsubishi Pharma Corp Metodo de produccion para una composicion que contiene proteinas.

Also Published As

Publication number Publication date
US5371196A (en) 1994-12-06
JPH04145031A (ja) 1992-05-19
EP0479597A2 (en) 1992-04-08
JP3145696B2 (ja) 2001-03-12
EP0479597A3 (en) 1993-02-24
EP0479597B1 (en) 1996-06-12
DE69120192T2 (de) 1996-10-10
DE69120192D1 (de) 1996-07-18
CA2052809A1 (en) 1992-04-06

Similar Documents

Publication Publication Date Title
ES2090255T3 (es) Procedimiento para producir preparaciones de inmunoglobulina a secretora.
GB2199328B (en) Use of a 5&#39; untranslated leader sequence of an rna virus to enhance translation
MX172861B (es) Procedimiento para inactivar microorganismos virales indeseables presentes en plasma o sus fracciones
ES2032807T3 (es) Pelicula de baja emisividad para tratamiento a alta temperatura.
ES2188583T3 (es) Polipeptidos para el virus de la hepatitis c (hcv).
ES2101077T3 (es) Procedimiento para la inactivacion de priones.
ITRM920590A0 (it) Sistema per la realizzazione distrutture in fibra di carbonio, e procedimento per detto, particolarmente idoneo per applicazioni aeronautiche.
SE8603560D0 (sv) Forfarande for framstellning av rostfria stalmaterial med hog hallfasthet och utomordentlig bearbetbarhet, och vilka icke mjuknar vid svetsning
YU51694A (sh) Postupak za dobijanje n-amino-1-hidroksi-alkilden-1,1-bifosfinskih kiselina
AT366786B (de) Gasturbinenanlage, insbesondere fuer den 6.000 - 10.000 kw bereich
SE7906546L (sv) Medel for upptining av is- och/eller snoteckta ytor
ATE179614T1 (de) Herpes simplex virus vp16 impfstoffe
DK0679150T3 (da) Pyroteknisk tågedannende sammensætnng til kamuflageformål og dens anvendelse i et tågedannende legeme
CO4970799A1 (es) Proceso de produccion para inmunoglobulina serica intraveno- sa y producto resultante
ES8303427A1 (es) &#34;un procedimiento para preparar compuestos de cefem&#34;.
EP0152072A3 (en) Pulsed light selective photolysis process for treatment of biological media and products made thereby
ES2049091T5 (es) Tecnica de cultivo fuera del suelo que utiliza materiales procedentes de substratos usados.
ATE49185T1 (de) Verfahren zur herstellung von halogen-magnesium- alanat und dessen verwendung.
IL69659A (en) 6-(2-(cyclic amino)ethylamino)tetrahydrotriazolo(3,4-a)phthalazines,their preparation and pharmaceutical compositions containing them
DK0609649T3 (da) &#34;Walking beam&#34;-ovn til accelereret opvarmning af blokke eller lignende
DE3370630D1 (en) Polyalkyldiazaspirodecanyl-acetic-acid derivatives, process for their preparation and their use as light protecting agents for organic polymers
DE3676792D1 (de) Oligomere diazaoxaspirodecane, ihre herstellung und ihre verwendung als lichtschutzmittel fuer polymere.
ES2080898T3 (es) Procedimiento para la preparacion de una ciclobutanona opticamente activa, un producto intermedio en la sintesis de un nucleosido de ciclobutano opticamente activo.
IT1187642B (it) Emoglobina a ridotti rischi da virus e procedimento per prepararla
ES2084657T3 (es) Agente para el tratamiento de los trastornos del sistema de transmision cerebro-neural.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 479597

Country of ref document: ES

FG2A Definitive protection

Ref document number: 479597

Country of ref document: ES